Tracked outbound links that support the site.
Primary tracked trading CTA seeded from the existing site settings.
BUY / SELLSee which coins need urgent review, which ones may be ready for profit management, and which setups still look constructive.
Coins with exit-risk or scam-style pressure that deserve immediate review.
Track when a watched coin moves from wait-or-avoid territory back into a cleaner starter or re-entry setup.
See which watched coins deserve a full staged build, which only allow a starter ladder, and which need a reclaim first.
| # | Name | Price | 24h | 1h | 7d | Trend | Buy Zone | Sell Watch | Scam Risk | Volume(24h) | Market Cap | Last 7 Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5787 | Museum of Crypto Art MOCA | $0.0386 | 4.06% | 0.04% | 7.62% | Breakdown Risk 29/100 | Wait For Confirmation 38/100 | Starter 0.00% | Hold Watch 18/100 | Low Risk 32/100 | $1,206 | $100.96K | |
| 250 | EUR CoinVertible EURCV | $1.16 | 0.37% | 0.04% | 0.25% | Neutral 50/100 | Wait For Confirmation 44/100 | Starter 0.00% | Hold Watch 18/100 | Low Risk 30/100 | $32.86M | $122.85M | |
| 250 | EUR CoinVertible EURCV | $1.16 | 0.37% | 0.04% | 0.25% | Weakening 36/100 | Avoid For Now 0/100 | Starter 0.00% | Hold Watch 28/100 | High Scam Watch 62/100 | $32.86M | $122.85M | |
| 5452 | Sway Social SWAY | $0.002509 | 0.89% | 0.14% | 9.83% | Weakening 34/100 | Wait For Confirmation 41/100 | Starter 0.00% | Hold Watch 18/100 | Low Risk 26/100 | $1,258 | $124.11K |

The UK Financial Conduct Authority has warned football clubs that sponsorship deals with unauthorised crypto firms could expose fans to financial harm while creating legal, money laundering and reputational risks…...
Read More
Bitcoin price is testing the key $65,000 support zone after Iran’s retaliatory strikes against the U.S. spooked investors, with charts suggesting a deeper slide toward $60,000 if bears remain in…...
Read More
NewLimit, a longevity biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in Series C funding to move its first age-reprogramming medicine toward human trials. Summary NewLimit…...
Read More


